Skip to main navigationSkip to main contentSkip to footer HealthSpring logo HealthSpring logo
Search
Español
  • Contact Us
    Are you already a member and have questions about your plan?

    For Medicare Advantage Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., Monday – Friday

    For Medicare Advantage Plan Members in Arizona, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., Monday – Friday


    For Medicare Prescription Drug Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., 7 days a week


    For Medicare Supplement Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., ET, Monday – Friday

    Member Log in
  • Contact Us
    Are you already a member and have questions about your plan?

    For Medicare Advantage Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., Monday – Friday

    For Medicare Advantage Plan Members in Arizona, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., Monday – Friday


    For Medicare Prescription Drug Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., 7 days a week


    For Medicare Supplement Plan Members, call us at
    (TTY: 711)
    8 a.m. – 8 p.m., ET, Monday – Friday

  • Home Medicare Member Resources Does Medicare Cover Weight-Loss Drugs?

    Does Medicare Cover GLP-1 Weight Loss Drugs?

    Find plans in your area.

    Or, call us at (TTY: 711)

    8 a.m. – 8 p.m., 7 days a week

    There are two ways to get coverage for GLP-1 medications: 

    Let’s talk more about GLP-1s, how they are covered under Medicare, and how you would qualify for the Medicare GLP-1 Bridge. 

    What Are GLP-1s?

    GLP-1 stands for glucagon-like peptide-1. GLP-1 is the mechanism at the center of the current generation of weight-loss drugs. 

    Since 2020, the FDA has approved four GLP-1 medications for chronic weight management in adults with obesity: Wegovy®, Zepbound®, Foundayo™ and Saxenda®.  

    The FDA has approved at least eight other GLP-1s for treating type 2 diabetes but not for weight management or weight loss. A few weight-loss GLP-1 medications are approved for other conditions, such as sleep apnea, and liver and heart health. 

    When Does Medicare Cover GLP-1s?

    By law, Medicare bans routine coverage for weight-loss drugs. 

    However, you might get Medicare coverage for GLP-1 weight-loss drugs if you have a Medicare prescription drug plan (Part D), and your medications are prescribed for reasons other than weight loss. Here are all FDA approvals for GLP-1 weight-loss drugs, and what indications Part D might cover: 

    Drug
    FDA-approved uses
    What Part D may cover
    Wegovy

    Manage weight

    Reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease, and who are either obese or overweight 

    Noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis

    Cardiovascular risks and MASH indications
    Zepbound

    Manage weight

    Moderate-to-severe obstructive sleep apnea in adults with obesity 

    Sleep apnea
    Foundayo
    Manage weight
    Not covered
    Saxenda
    Manage weight
    Not covered

    Through the end of 2027, there is one other option for Medicare patients who might qualify for a weight-loss drug: the Medicare GLP-1 Bridge. 

    What Is the Medicare GLP-1 Bridge Program?

    The Medicare GLP-1 Bridge program allows eligible patients with Part D prescription coverage to get a weight-loss medication for $50 per month. 

    The Centers for Medicare & Medicaid Services (CMS) began the short-term test program on July 1, 2026. It ends on Dec. 31, 2027. The GLP-1s available under the Medicare GLP-1 Bridge are: 

    The single-dose Zepbound pen and Zepbound vials are not covered. Saxenda also isn’t covered under the Medicare GLP-1 Bridge. 

    Part D vs. Medicare GLP-1 Bridge

    Here is how Part D coverage works, compared to the Medicare GLP-1 Bridge:

    Question
    Medicare GLP-1 Bridge
    Part D
    Who runs it?
    The Centers for Medicare & Medicaid Services (CMS) (government program)
    Your plan (private insurance companies such as HealthSpring)
    What GLP-1s does it cover?

    Medications prescribed for weight-loss only: 

    • Foundayo 

    • Wegovy 

    • Zepbound (KwikPen only) 

    Medications prescribed for any approved use except weight loss. Examples: 

    • Type 2 diabetes 

    • Sleep apnea 

    • MASH 

    • Kidney health 

    • Heart health 

    What’s the cost?
    $50 per month co-pay (this doesn’t count toward any Part D deductibles or out-of-pocket maximums)
    Costs depend on your plan, and whether you’ve met your maximum spending cap.
    Does this replace my Part D coverage?
    No
    No

    How Do I Sign Up for the Medicare GLP-1 Bridge?

    You must meet one of these health requirements to quality for the Medicare GLP-1 Bridge: 

    You must have a Medicare prescription drug plan (Part D) to be considered for the Medicare GLP-1 Bridge. However, your Part D insurer doesn’t approve your eligibility or cover your costs.

    Instead, your doctor submits a prior authorization request and your prescription to a CMS central processor. That processor reviews the documentation to ensure you qualify. After you pay your $50, CMS covers the rest of the $250 monthly cost of the weight-loss drug directly. Your Part D insurer doesn’t pay anything, and your monthly payment doesn’t apply to your Part D maximum payment cap.

    Why Wasn’t I Approved for the Medicare GLP-1 Bridge?

    Even if you meet the health requirements, you cannot be approved for the Medicare GLP-1 Bridge if: 

    Frequently Asked Questions

    Is Ozempic covered by Medicare? 

    Ozempic®, primarily used to treat type 2 diabetes, is not approved for weight loss. That’s why it isn’t subject to the legal ban on Medicare covering weight-loss medicine. Check with your Part D plan to confirm Ozempic is on its formulary, a list of covered drugs. In 2026 and 2027, Ozempic is available in all HealthSpring drug plans, subject to prior authorization and quantity limits. 

    What GLP-1 drugs are covered by Medicare?

    Any GLP-1 medication can be covered by Medicare Part D as long as it isn’t intended for weight loss or weight management. GLP-1 drugs approved to treat other conditions – such as type 2 diabetes, moderate to severe sleep apnea, and heart, kidney and liver health for high-risk individuals – may be covered by a Medicare Part D plan. 

    Check with your own plan to confirm which GLP-1s are on its formulary. A formulary is a list of drugs covered by your health plan. From July 1, 2026, to Dec. 31, 2027, you might be able to get coverage for a GLP-1 weight-loss drug through a program called the Medicare GLP-1 Bridge. 

    How do I qualify for the Medicare GLP-1 Bridge?

    Follow these steps: 

    1. Have a Medicare prescription plan. You must have Part D coverage in order to qualify. If you have a Medicare Advantage plan, it likely includes a Part D prescription drug plan. 

    2. Talk to your doctor or primary-care provider. They will check whether you meet body-mass index (BMI) and health requirements for the Medicare GLP-1 Bridge, and whether they believe a weight-loss medication is right for you. 

    3. Make sure your drug is covered. The Medicare GLP-1 Bridge is limited to Foundayo, Wegovy (injection and tablet) and Zepbound (KwikPen only).  

    4. Get a prior authorization. Your doctor or primary-care provider must submit a prior authorization to the Centers for Medicare & Medicaid Services (CMS), which reviews the request to see if you qualify. Your Part D insurer isn’t part of this process. Note: If you’re already taking any of these medications for an approved condition other than obesity, or might qualify to take one for reasons other than weight loss, you might be not eligible. 

    5. Fill your prescription at a participating pharmacy. If you’re approved, you’ll pay $50 for a 30-day supply.

    How long is the Medicare GLP-1 Bridge available?

    The Medicare GLP-1 Bridge is available from July 1, 2026, to Dec. 31, 2027. 

    What happens when the Medicare GLP-1 Bridge program ends?

    It isn’t clear yet what will happen. There are no stated plans to extend the program, nor has legislation passed that would allow Medicare to cover weight-loss medications. 

    I don’t have a Medicare prescription drug plan. Can I get weight-loss drugs through the Medicare GLP-1 Bridge?

    No. You must have a Medicare prescription drug plan to participate in the Medicare GLP-1 Bridge. The program, if you meet certain qualifications, allows you to receive Wegovy, Zepbound or Foundayo for $50 per month through Dec. 31, 2027. 

    There are multiple ways to get Medicare prescription drug coverage: 

    Does my monthly Medicare GLP-1 Bridge payment apply toward my Part D maximum?

    No. The difference between the $50 a month you pay, and the monthly $250 cost of the drugs is covered by the Centers for Medicare & Medicaid Services, not your plan. Therefore, your payment doesn’t count toward your Part D maximum.

    How can I get my Medicare Part D plan to cover GLP-1s?

    To have Medicare cover a GLP-1 prescription, you need to have a prescription drug plan (Part D), meet the coverage criteria and go through the proper steps: 

    1. Have a covered diagnosis. Medicare Part D will cover a GLP-1 only if it’s medically necessary for an FDA-approved use, as long as it isn’t prescribed specifically for weight loss. 

    2. Have the specific GLP-1 on your plan’s formulary. A formulary is a list of drugs your plan will cover. 

    3. Get a prescription and possibly prior authorization. When your doctor prescribes a GLP-1, the pharmacy or plan might require a prior authorization. That means they want to review whether the prescription is medically necessary, and if it’s the right drug for you. Work with your doctor to submit any needed paperwork showing why the GLP-1 is needed. 

    4. Fill the prescription at a network pharmacy. Use a pharmacy in your plan’s network (or mail order) to ensure coverage. At pickup, you’ll pay your plan’s co-pay/coinsurance.